Innova Captab Q3 results: revenue up 42%, declares Rs 2 interim dividend

Revenue Growth 20pctResults View source PDF Explain this filing

INNOVACAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹651.30

prior close

₹665.45

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.1%+5.0% vs market

Pharmaceuticals peers, median of 155sector-1.5%+4.4% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+11.2

10m

+10.9

15m

+11.4

30m

+8.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-2.1+5.0-1.5+4.4

Next day

+6.3-2.0+8.3-2.1+8.4

+6.9-0.0+7.0-1.0+7.9

+3.2-0.4+3.6-1.4+4.6

+5.3+1.4+3.9-1.1+6.4

+5.8+0.1+5.7-1.4+7.1

+9.8+5.2+4.6+1.4+8.4

15d

+3.3+3.7-0.3+0.0+3.3

+5.9+3.5+2.4+0.3+5.7

+3.3-9.4+12.7-9.9+13.3

+11.3+9.0+2.3+2.5+8.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Innova Captab reported Q3 FY26 consolidated revenue of Rs 4,502.93 million, up 42% from Rs 3,164.62 million a year ago. Nine-month revenue rose 27% to Rs 11,822.16 million. Q3 consolidated PAT grew 23% to Rs 421.49 million; 9M PAT rose 4% to Rs 1,028.34 million. Standalone Q3 PAT was Rs 279.01 million. Board declared an interim dividend of Rs 2 per share (20% of face value). Record date is January 30, 2026. Auditors gave an unmodified review.

Likely market impact

Strong top-line growth plus interim dividend signal healthy momentum, though nine-month PAT growth was modest at the consolidated level.